36 Votes
ANALYSIS | Health Canada drug approval policy lacks key power Nov 30, 2011 3:25 PM ET Health Canada's inability to demand drug safety updates has drawn concern from the auditor general - and is particularly important for the g
http://c.moreover.com —
A growing number of drugs in Canada are receiving conditional approval designed to speed promising drugs to market. But concern has been raised about Health Canada's ability to compel drugmakers to provide safety information. AP Photo In his fall update
Comments